The Resistance of Human APOBEC3H to HIV-1 NL4-3 Molecular Clone Is Determined by a Single Amino Acid in Vif
Open Access
- 28 February 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (2) , e57744
Abstract
Some human APOBEC3 cytidine deaminases have antiviral activity against HIV-1 and other retroviruses. The single deaminase domain APOBEC3H (A3H) enzyme is highly polymorphic and multiple A3H haplotypes have been identified. A3H haplotype II (A3H-hapII) possesses the strongest activity against HIV-1. There remains, however, uncertainty regarding the extent to which A3H-hapII is sensitive to HIV-1 Vif mediated degradation. We tested, therefore, the two different reference Vif proteins widely used in previous studies. We show that A3H-hapII is resistant to NL4-3 Vif while it is efficiently degraded by LAI Vif. Co-immunoprecipitation assays demonstrate that LAI Vif, but not NL4-3 Vif associates with A3H-hapII. Chimeras between NL4-3 and LAI Vif identify the amino acid responsible for the differential degradation activity: A histidine at position 48 in Vif confers activity against A3H-hapII, while an asparagine abolishes its anti-A3H activity. Furthermore, the amino acid identity at position 48 only affects the degradation of A3H-hapII, whereas recognition of and activity against human A3D, A3F and A3G are only minimally affected. NL4-3 encoding 48H replicates better than NL4-3 WT (48N) in T cell-lines stably expressing A3H hapII, whereas there is no fitness difference in the absence of APOBEC3. These studies provide an explanation for the conflicting reports regarding A3H resistance to Vif mediated degradation.Keywords
This publication has 30 references indexed in Scilit:
- APOBEC3H haplotypes and HIV-1 pro-viral vif DNA sequence diversity in early untreated human immunodeficiency virus–1 infectionHuman Immunology, 2011
- Lentiviral Vif Degrades the APOBEC3Z3/APOBEC3H Protein of Its Mammalian Host and Is Capable of Cross-Species ActivityJournal of Virology, 2010
- A Single Amino Acid Difference in Human APOBEC3H Variants Determines HIV-1 Vif SensitivityJournal of Virology, 2010
- Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeuticsExpert Reviews in Molecular Medicine, 2010
- APOBEC proteins and intrinsic resistance to HIV-1 infectionPhilosophical Transactions of the Royal Society B: Biological Sciences, 2008
- Sole copy of Z2‐type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV‐1.The FASEB Journal, 2008
- Antiretroelement Activity of APOBEC3H Was Lost Twice in Recent Human EvolutionCell Host & Microbe, 2008
- Cytidine deamination induced HIV-1 drug resistanceProceedings of the National Academy of Sciences, 2008
- Human Cytidine Deaminase APOBEC3H Restricts HIV-1 ReplicationJournal of Biological Chemistry, 2008
- Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcriptsNature, 2003